A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions.
KSHV inflammatory cytokine syndrome
KSHV-MCD
flow cytometry
lambda-restricted plasmablasts
Journal
British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
03
10
2022
received:
16
06
2022
accepted:
05
10
2022
pubmed:
21
10
2022
medline:
7
2
2023
entrez:
20
10
2022
Statut:
ppublish
Résumé
A biopsy of lymphoid tissue is currently required to diagnose Kaposi sarcoma-associated herpesvirus (KSHV)-associated multicentric Castleman disease (KSHV-MCD). Patients showing clinical manifestations of KSHV-MCD but no pathological changes of KSHV-MCD are diagnosed as KSHV inflammatory cytokine syndrome. However, a lymph node biopsy is not always feasible to make the distinction. A pathognomonic feature of lymph nodes in KSHV-MCD is the expansion of KSHV-infected, lambda-restricted but polyclonal plasmablasts. To investigate whether these cells also reside in extra-nodal sites, effusion from 11 patients with KSHV-MCD and 19 with KSHV inflammatory cytokine syndrome was analysed by multiparametric flow cytometry. A distinct, lambda-restricted plasmablastic population (LRP) with highly consistent immunophenotype was detected in effusions in 8/11 patients with KSHV-MCD. The same population was also observed in 7/19 patients with KSHV inflammatory cytokine syndrome. The detection of LRP stratified KSHV inflammatory cytokine syndrome into two clinically distinct subgroups; those with detectable LRP closely resembled KSHV-MCD, showing similar KSHV viral load, comparable severity of thrombocytopenia and hypoalbuminaemia, and similar incidences of hepatosplenomegaly. Collectively, the detection of LRP by flow cytometry can serve as a valuable tool in diagnosing KSHV-MCD. KSHV inflammatory cytokine syndrome with LRP in effusions may represent a liquid-form of KSHV-MCD.
Identifiants
pubmed: 36264007
doi: 10.1111/bjh.18518
pmc: PMC10165722
mid: NIHMS1847480
doi:
Substances chimiques
Cytokines
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
462-475Subventions
Organisme : NCI NIH HHS
ID : 75N91019D00024
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201500003I
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Published 2022. This article is a U.S. Government work and is in the public domain in the USA.
Références
Pathologica. 2021 Oct;113(5):339-353
pubmed: 34837092
Blood. 2000 Feb 15;95(4):1406-12
pubmed: 10666218
AIDS. 2021 Jan 1;35(1):53-62
pubmed: 33273183
Blood. 1995 Aug 15;86(4):1276-80
pubmed: 7632932
J Virol Methods. 2001 Feb;91(2):109-17
pubmed: 11164492
Blood Adv. 2021 Mar 23;5(6):1660-1670
pubmed: 33720337
Front Microbiol. 2012 Mar 02;3:73
pubmed: 22403576
Blood. 2001 Apr 1;97(7):2130-6
pubmed: 11264181
Blood. 2018 Nov 29;132(22):2323-2330
pubmed: 30487129
Clin Infect Dis. 2016 Mar 15;62(6):730-738
pubmed: 26658701
Clin Infect Dis. 2010 Aug 1;51(3):350-8
pubmed: 20583924
J Clin Pathol. 2007 May;60(5):524-8
pubmed: 16816169
Mod Pathol. 2017 May;30(5):745-760
pubmed: 28084335
Eur J Haematol. 2013 Dec;91(6):497-503
pubmed: 23992152
Hematol Oncol Clin North Am. 2018 Feb;32(1):75-88
pubmed: 29157621
J Virol. 1999 May;73(5):4181-7
pubmed: 10196314
Clin Infect Dis. 2008 Sep 1;47(5):684-8
pubmed: 18652555
Haematologica. 2002 Apr;87(4):339-43
pubmed: 11940475
Histopathology. 2008 Nov;53(5):513-24
pubmed: 18983461
Curr Opin Pulm Med. 2001 Jul;7(4):202-9
pubmed: 11470975
Semin Diagn Pathol. 2016 Sep;33(5):294-306
pubmed: 27296355
Science. 1994 Dec 16;266(5192):1865-9
pubmed: 7997879